|View printer-friendly version|
|September 19, 2011 9:22 a.m.|
|Teva to Present at the UBS Global Life Sciences Conference|
JERUSALEM, Sep 19, 2011 (BUSINESS WIRE) -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Life Sciences Conference with William Marth, President & CEO, Teva Pharmaceuticals - Americas, presenting on Tuesday, September 20, 2011 in New York.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 42,000 people around the world and reached $16.1 billion in net sales in 2010.
SOURCE: Teva Pharmaceutical Industries Ltd.